Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0
NCT03995706
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
26
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma
Interventions
DRUG:
Sacituzumab Govitecan
Sponsor
The University of Texas Health Science Center at San Antonio
Collaborators
[object Object]